Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.

Estefanía García-GuerreroRalph GötzSören DooseMarkus SauerAlfonso Rodríguez-GilThomas NerreterK Martin KortümJosé A Pérez-SimónHermann EinseleMichael HudecekSophia Danhof

Published in: Leukemia (2021)

Keyphrases

multiple myeloma
poor prognosis
induced apoptosis
cell cycle arrest
signaling pathway
long non coding rna
cell proliferation
binding protein
oxidative stress
pi k akt